Skip to main content

Global Bronchoscopy Market Size to Reach USD 4.22 Billion in 2030 | Emergen Research

Advancements in the number of features in bronchoscopic instruments are a major factor driving revenue growth

Vancouver, Aug. 22, 2023 (GLOBE NEWSWIRE) — The global bronchoscopy market achieved a value of USD 2.54 Billion in 2021 and is projected to maintain a revenue Compound Annual Growth Rate (CAGR) of 5.8% throughout the anticipated period, as per the most recent analysis conducted by Emergen Research. The escalation in the prevalence of respiratory ailments serves as a significant driver for the market’s revenue upsurge. An influential factor contributing to the advancement of revenue is the proficiency of bronchoscopy technologies in enhancing visibility of internal anatomical complexities within the respiratory system. The utilization of a bronchoscope’s camera empowers medical professionals to visually inspect a patient’s lungs via the broader air passages. The deficiency of precise visualization of respiratory tissues is believed to be a leading cause of fatalities associated with respiratory diseases. Notably, bronchoscopy has substantially revolutionized the realm of bio-imaging, profoundly augmenting the utilization of bronchoscopy techniques.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @
https://www.emergenresearch.com/request-sample/1515

The upward trajectory of revenue growth in the bronchoscopy market is significantly propelled by the continuous advancements in bronchoscopy-related technologies. An eminent catalyst behind the market’s revenue surge lies in the widening scope of research and development endeavors aimed at devising innovative bronchoscopy platforms tailored for chronic ailment management.

Conversely, the presence of risk factors pertaining to bronchoscopes stands as a notable restraint. While bronchoscopy procedures are generally characterized by their safety, there exists a marginal potential for occurrences such as airway bleeding. Additionally, instances like lung infection (pneumonia) and partial lung collapse (pneumothorax) can be attributed to the utilization of bronchoscopy techniques.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1515

Scope of Research

Report DetailsOutcome
Market size in 2021USD 2.54 Billion
CAGR (2022–2030)5.8%
Revenue forecast to 2030USD 4.22 Billion
Base year for estimation2021
Historical data2019–2020
Forecast period2022–2030
Quantitative unitsRevenue in USD Billion and CAGR in % from 2022 to 2030
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredType, application, end-use, and region
Regional scopeNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scopeU.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA
Key companies profiledTeleflex Incorporated; Olympus Corporation; Ambu A/s; Karl Storz; Fujifilm Holdings Corporation; Boston Scientific Corporation; Cogentix Medical; Medtronic; Cook Medical; EMOS Technology GmbH; Broncus Medical Inc.
Customization scope10 hours of free customization and expert consultation

Major Companies and Competitive Landscape

The global bronchoscopy market is fairly fragmented, with many large and medium-sized players accounting for a majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective bronchoscopy products. Some major players included in the global bronchoscopy market report are:

  • Teleflex Incorporated
  • Olympus Corporation
  • Ambu A/s.
  • Karl Storz.
  • Fujifilm Holdings Corporation
  • Boston Scientific Corporation
  • Cogentix Medical
  • Medtronic
  • Cook Medical
  • EMOS Technology GmbH
  • Broncus Medical Inc.

Strategic Development

  • On November 15, 2022, Fujifilm made the new launch of the EB-710P Slim Video Bronchoscope in India. The EB-710P is a slim endoscope with a CMOS sensor that is incredibly small. The tip is only 4.1 mm in diameter owing to this technology, which makes it considerably easier to pierce the lung’s periphery than a typical method. In addition, there is a rotation mechanism that enables the operator to safely reposition the endoscope to where it was before the withdrawal.
  • On August 2, 2022, the fifth generation Ascope 5 Broncho bronchoscope portfolio from Ambu received Food and Drug Administration (FDA) approval. Ambu now has access to operating rooms where high clinical requirements procedures are performed owing to the U.S. and EU approving the fifth generation of single-use bronchoscopes.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/1515

Some Key Highlights From the Report

  • The flexible bronchoscope is accounted for the largest market revenue share in 2021. The flexible category, which boasts exceptional video quality and a high level of cost-effectiveness, accounts for a sizeable amount of income. The fiberoptic sub-segment has been dominating the flexible market owing to its several benefits, including high-quality videos that make tumors and infections in deeper levels of bronchioles simple to see.
  • Oncology accounted for the largest revenue share in 2021. The major factors driving the growth of the segment are the rising prevalence of pulmonary cancer and patient awareness of lung cancer screening.
  • Hospitals accounted for the largest revenue share in 2021. The segment’s growth is mostly driven by an increase in the number of patients on the planet as a result of cases of lung cancer, cystic fibrosis, TB, sarcoidosis, influenza, and other diseases. A persistent cough, an infection, or an unexpected finding on a chest X-ray or other test are typical reasons why a bronchoscopy is necessary.
  • North America accounted for the largest revenue share in 2021. The region’s economic growth is significantly driven by the rising financing from governmental and non-governmental organizations for biomedical research, notably respiratory research. One of the main factors driving this region’s market revenue growth is the rising number of industry participants investing in bronchoscopy devices.

Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/bronchoscopy-market

Emergen Research has segmented the global bronchoscopy market on the basis of medical application, product type, end-use, and region:

  • Type Outlook (Revenue, USD Billion; 2019-2030)
    • Flexible
    • Rigid
    • Others
  • Application Outlook (Revenue, USD Billion; 2019-2030)
    • Oncology
    • Pneumonia
    • Pulmonary tuberculosis
    • Others
  • End-Use Outlook (Revenue, USD Billion; 2019-2030)
    • Hospitals
    • Molecular diagnostic laboratories
    • Medical clinics
    • Others
  • Regional Outlook (Revenue, USD Billion; 2019-2030)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Coronary Stents Products Market, By Product Type (Bare Metal Stents, Drug-Eluting Stents, and Bioresorbable Stents), By End-Use (Hospitals, Cardiac Centers, and Others), and By Region Forecast to 2032

Peripheral Vascular and Biliary Stents Market, By Product Type (Peripheral Vascular Stents and Biliary Stents), By Material (Metal Stents and Polymer Stents), By End-Use, and By Region Forecast to 2032

Revascularization Products Market, By Application (Off-Pump Coronary Artery Bypass (OPCAB), Coronary Artery Bypass Graft (CABG), Others), By End-Use (Hospitals, Cardiac Centers, and Ambulatory Surgical Centers) and By Region Forecast to 2032

Peripheral Vascular Chronic Total Occlusion Devices Market, By Product Type (Extraluminal Devices, Balloon Catheters, Guidewires, Stents, and Others), By End-Use (Hospitals, Cardiac Centers, and Others), and By Region Forecast to 2032

Coronary Guidewires and Accessories Products Market, By Product Type (Guidewires and Accessories), By Material (Stainless Steel, Nitinol, and Others), By End-use, By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Bronchoscopy Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-bronchoscopy-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.